Novo Nordisk of North America, Inc. v. Genentech, Inc.
District Court, S.D. New York
1Opinion of the Court
DEFENDANT’S MOTION TO DISMISS CLAIMS THREE AND FOUR OF PLAINTIFFS’ COMPLAINT
MOTLEY, District Judge.
In this case, plaintiffs seek a declaratory judgment that United States Patent Nos. 4,342,832 (the ’832 patent), 4,601,980 (the ’980 patent), 4,366,246 (the ’246 patent), and 5,221,619 (the ’619 patent) are invalid and not infringed by plaintiffs. This action arises under the Declaratory Judgment Act, 28 U.S.C. §§ 2201 and 2202, and the patent laws of the United States, Title 35, United States Code. Jurisdiction is based on 28 U.S.C. § 1338 while venue is based on 28 U.S.C. 1391(b) and (c).
The…
2Cases cited23 opinions
- Conley v. GibsonSupreme Court of the United States · 1957
- Hishon v. King & SpaldingSupreme Court of the United States · 1984
- United States v. Grinnell Corp.Supreme Court of the United States · 1966
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
- United Mine Workers v. PenningtonSupreme Court of the United States · 1965
18 more not listed; retrieve them via the Exa API.
3Cited by8 opinions
- Bristol-Myers Squibb Co. v. Ben Venue LaboratoriesDistrict Court, D. New Jersey · 2000
- Bristol-Myers Squibb Co. v. Copley Pharmaceutical, Inc.District Court, D. Massachusetts · 2000
- Ragner Tech. Corp. v. BerardiDistrict Court, D. New Jersey · 2018
- Giant Group, Ltd. v. SandsDistrict Court, S.D. New York · 2001
- Amgen, Inc. v. F. Hoffmann-La Roche Ltd.District Court, D. Massachusetts · 2007
3 more not listed; retrieve them via the Exa API.